Suppression of β-cell secretion by somatostatin does not fully reverse the disproportionate proinsulinemia of type 2 diabetes

Diabetes

Volumn 53, Issue SUPPL. 3, 2004, Pages

  Røder, Michael E ^a,b   Kahn, Steven E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; PROINSULIN; SOMATOSTATIN;

ADULT; BASAL METABOLIC RATE; CELL FUNCTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROINSULIN; REFERENCE VALUES; SOMATOSTATIN;

EID: 9444233893     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.suppl_3.S22     Document Type: Conference Paper

References (22)

1. Mako ME, Starr JI, Rubenstein AH: Circulating proinsulin in patients with maturity onset diabetes. Am J Med 63:865-869, 1977
2. Røder ME, Porte D Jr, Schwartz RS, Kahn SE: Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608, 1998
3. Mykkänen L, Haffner SM, Hales CN, Rönnemaa T, Laakso M: The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990-1995, 1997
4. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr: Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990
5. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173-179, 1995
6. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, American Diabetes Association GENNID Study Group: β-Cell function is the major determinant of oral glucose tolerance in four ethnic groups in the United States. Diabetes 51:2170-2178, 2002
7. Porte D Jr, Kahn SE: Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction? Diabetes 38:1333-1336, 1989
8. Rhodes CJ, Alarcon C: What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43:511-517, 1994
9. Ward WK, Paquette TL, Frank BH, Porte D Jr: A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin. Clin Chem 32:728-733, 1986
10. Morgan DR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12:115-126, 1963
11. Heding LG: Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548, 1975
12. Faber OK, Markussen J, Naithani VK, Binder C: Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe-Seyler's Z Physiol Chem 357:751-757, 1976
13. Røder ME, Dinesen B, Hartling SG, Houssa P, Vestergaard H, Sodoyez-Goffaux F, Binder C: Intact proinsulin and B-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 22:609-614, 1999
14. Kahn SE, Halban PA: Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725-1732, 1997
15. Nauck MA, Siegel EG, Creutzfeldt W: Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas 6:645-652, 1991
16. Hartling SG, Røder ME, Dinesen B, Binder C: Proinsulin, C-peptide, and insulin in normal subjects during an 8-h hyperglycemic clamp. Eur J Endocrinol 134:197-200, 1996
17. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ Jr, Porte D Jr: Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38:562-568, 1989
18. Wang P, Abbasi F, Carantoni M, Chen YI, Azhar S, Reaven GM: Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers. J Clin Endocrinol Metab 82:3221-3224, 1997
19. Røder ME, Schwartz RS, Prigeon RL, Kahn SE: Reduced pancreatic B-cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels. J Clin Endocrinol Metab 85:2275-2280, 2000
20. Laedtke T, Kjems L, Pørksen N, Schmitz O, Veldhuis J, Kao PC, Butler PC: Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am J Physiol Endocrinol Metab 279:E520-E528, 2000
21. Glaser B, Leibovich G, Nesher R, Hartling S, Binder C, Cerasi E: Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinologica 118:365-373, 1988
22. Rachman J, Levy JC, Barrow BA, Manley SE, Turner RC: Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Diabetes 46:1557-1562, 1997